NATIONAL CANCER CENTER;ASAHI KASEI PHARMA CORPORATION
发明人:
Takahiro Ochiya,Fumitaka Takeshita
申请号：
US14421337
公开号：
US09790492B2
申请日:
2013.08.19
申请国别(地区):
US
年份:
2017
代理人:
摘要：
[Problem] To provide the following: an agent for treating cancer, particularly an agent for inhibiting cancer cell proliferation or an agent for inhibiting or preventing cancer metastasis； drug that uses the agent； a method for assessing the effect of cancer treatment； a method for estimating the prognosis of cancer treatment； a method for screening for a substance having a cancer proliferation-inhibiting effect； and a method for screening a substance having a cancer metastasis-impeding effect.[Solution] Provided is a drug containing a nucleic acid formed from a nucleotide sequence having sequence identity of 70% or greater with at least sequence No. 1 or No. 2, wherein the nucleic acid shows protein expression-inhibiting activity.
